Review article: From allergen genes to new forms of allergy diagnosis and treatment

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Allergy. European Journal of Allergy and Clinical Immunology

• Publication date

  2008-02-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1398-9995.2007.01609.xPMID 18269675
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of allergen-specific immunotherapy.

  2007cited by this paper
• Exposure to a farming environment has allergen-specific protective effects on TH2-dependent isotype switching in response to common inhalants.

  2007cited by this paper
• Genetic Engineering of the Major Timothy Grass Pollen Allergen, Phl p 6, to Reduce Allergenic Activity and Preserve Immunogenicity1

  2007cited by this paper
• Mechanisms of allergen specific immunotherapy – T‐cell tolerance and more

  2006cited by this paper
• Hypoallergenic fragment of Par j 2 increases functional expression of Toll‐like receptors in atopic children

  2006cited by this paper
• Immunoregulation by targeting T cells in the treatment of allergy and asthma.

  2006cited by this paper
• Comparison of purified Dermatophagoides pteronyssinus allergens and extract by two‐dimensional immunoblotting and quantitative immunoglobulin E inhibitions

  2005cited by this paper
• A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination.

  2005cited by this paper
• Allergen-specific immunotherapy with recombinant grass pollen allergens.

  2005cited by this paper
• Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity.

  2005cited by this paper
• Cytokine and Antibody Responses in Birch-Pollen-Allergic Patients Treated with Genetically Modified Derivatives of the Major Birch Pollen Allergen Bet v 1

  2005cited by this paper
• Vaccination with genetically engineered allergens prevents progression of allergic disease

  2004cited by this paper
• Strategies for converting allergens into hypoallergenic vaccine candidates.

  2004cited by this paper
• Non‐anaphylactic surface‐exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination

  2004cited by this paper
• Grass Pollen Immunotherapy Induces Mucosal and Peripheral IL-10 Responses and Blocking IgG Activity1

  2004cited by this paper
• Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1

  2004cited by this paper
• Component‐resolved diagnosis of house‐dust mite allergy with purified natural and recombinant mite allergens

  2004cited by this paper
• Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells

  2004cited by this paper
• Allergen‐specific immunotherapy with a monophosphoryl lipid A‐adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy‐induced blocking antibodies

  2003cited by this paper
• Renaissance of the Blocking Antibody Concept in Type I Allergy

  2003cited by this paper
• Analysis of the sensitization profile towards allergens in central Africa

  2003cited by this paper
• Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment

  2002cited by this paper
• Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial.

  2002influential reference
• Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System™

  2002cited by this paper
• A major IgE epitope-containing grass pollen allergen domain from Phl p 5 folds as a four-helix bundle.

  2002cited by this paper
• Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity.

  2002cited by this paper
• Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE‐binding capacity: candidates for grass pollen‐specific immunotherapy

  2002cited by this paper
• Specific immunotherapy – the induction of new IgE‐specificities?

  2002cited by this paper
• Allergen-immunostimulatory oligodeoxynucleotide conjugate: a novel allergoid for immunotherapy

  2002cited by this paper
• Characterization and Immunobiology of House Dust Mite Allergens

  2002cited by this paper
• Recombinant Allergens with Reduced Allergenicity but Retaining Immunogenicity of the Natural Allergens: Hybrids of Yellow Jacket and Paper Wasp Venom Allergen Antigen 5s1

  2001cited by this paper
• Release of allergen-bearing cytoplasm from hydrated pollen: a mechanism common to a variety of grass (Poaceae) species revealed by electron microscopy.

  2001cited by this paper
• The germless theory of allergic disease: revisiting the hygiene hypothesis

  2001cited by this paper
• Human basophils: mediator release and cytokine production.

  2001cited by this paper
• Allergen-Derived T Cell Peptide-Induced Late Asthmatic Reactions Precede the Induction of Antigen-Specific Hyporesponsiveness in Atopic Allergic Asthmatic Subjects1

  2001cited by this paper
• Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination

  2001cited by this paper
• Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1

  2001cited by this paper
• Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild‐type by skin prick and intradermal testing: results obtained in a French population

  2000cited by this paper
• Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy.

  2000cited by this paper
• Expulsion of allergen-containing materials from hydrated rye grass (Lolium perenne) pollen revealed by using immunogold field emission scanning and transmission electron microscopy.

  2000cited by this paper
• Safety of allergen‐specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side‐effects during induction treatment

  2000cited by this paper
• What are the important allergens in grass pollen that are linked to human allergic disease?

  2000cited by this paper
• T Cell Epitope-Containing Hypoallergenic Recombinant Fragments of the Major Birch Pollen Allergen, Bet v 1, Induce Blocking Antibodies1

  2000cited by this paper
• Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen bet v 1 and to recombinant bet v 1 wild type in skin chamber fluids collected from birch pollen-allergic patients.

  2000cited by this paper
• Localization of a major allergen, Der p 2, in the gut and faecal pellets of Dermatophagoides pteronyssinus

  2000cited by this paper
• Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity.

  2000cited by this paper
• Signalling through the high-affinity IgE receptor Fc epsilonRI.

  1999cited by this paper
• Immunoglobulin E–independent Major Histocompatibility Complex–restricted T Cell Peptide Epitope–induced Late Asthmatic Reactions

  1999cited by this paper
• An immunoglobulin-like fold in a major plant allergen: the solution structure of Phl p 2 from timothy grass pollen.

  1999cited by this paper
• "Allergen engineering": variants of the timothy grass pollen allergen Phl p 5b with reduced IgE-binding capacity but conserved T cell reactivity.

  1999cited by this paper
• The safety and efficacy of ALLERVAX CAT in cat allergic patients.

  1999cited by this paper
• Towards defining the full spectrum of important house dust mite allergens

  1999cited by this paper
• Calcium‐dependent immunoglobulin E recognition of the apo‐ and calcium‐bound form of a cross‐reactive two EF‐hand timothy grass pollen allergen, Phl p 7

  1999cited by this paper
• Genetically Engineered and Synthetic Allergen Derivatives: Candidates for Vaccination against Type I Allergy

  1999cited by this paper
• Clinical Evaluation of Genetically Engineered Hypoallergenic rBet v 1 Derivatives

  1999cited by this paper
• The recombinant allergen‐based concept of component‐resolved diagnostics and immunotherapy (CRD and CRIT)

  1999cited by this paper
• Genetic Engineering of Recombinant Hypoallergenic Oligomers of the Major Birch Pollen Allergen, Bet v 1: Candidates for Specific Immunotherapy

  1999cited by this paper
• Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from Timothy grass (Phleum pratense) pollen.

  1999cited by this paper
• The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology.

  1999cited by this paper
• The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology.

  1999cited by this paper
• The Biological Function of Allergens: Relevant for the Induction of Allergic Diseases?

  1998cited by this paper
• Preserved epitope‐specific T cell activation by recombinant Bet v 1‐MBP fusion proteins

  1998cited by this paper
• Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper.

  1998influential reference
• IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE.

  1998cited by this paper
• Engineering of hypoallergenic mutants of the Brassica pollen allergen, Bra r 1, for immunotherapy

  1998cited by this paper
• Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.

  1998cited by this paper
• Recombinant allergens

  1998cited by this paper
• Modulation of IgE reactivity of allergens by site‐directed mutagenesis: potential use of hypoallergenic variants for immunotherapy

  1998cited by this paper
• Allergy review series II : Recombinant allergens

  1998cited by this paper
• Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation.

  1998cited by this paper
• Division of the major birch pollen allergen, Bet v 1, into two non-anaphylactic fragments.

  1997cited by this paper
• Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T‐cell clones specific for Phi p 1, a major grass pollen allergen

  1997cited by this paper
• Comparative degree and type of sensitization to common indoor and outdoor allergens in subjects with allergic rhinitis and/or asthma

  1997cited by this paper
• Investigation of different recombinant isoforms of grass group-V allergens (timothy grass pollen) isolated by low-stringency cDNA hybridization--antibody binding capacity and allergenic activity.

  1997cited by this paper
• Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy.

  1997cited by this paper
• Recombinant allergen fragments as candidate preparations for allergen immunotherapy.

  1997cited by this paper
• High-level expression in Escherichia coli and purification of recombinant plant profilins: comparison of IgE-binding capacity and allergenic activity.

  1996cited by this paper
• Comparison of recombinant timothy grass pollen allergens with natural extract for diagnosis of grass pollen allergy in different populations.

  1996cited by this paper
• Possible induction of food allergy during mite immunotherapy

  1996cited by this paper
• Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2.

  1996cited by this paper
• Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2.

  1996cited by this paper
• Prevalence of asthma and asthma-like symptoms in three French cities.

  1995cited by this paper
• Complementary DNA cloning of the major allergen Phl p I from timothy grass (Phleum pratense); recombinant Phl p I inhibits IgE binding to group I allergens from eight different grass species.

  1994cited by this paper
• cDNA cloning and expression of timothy grass (Phleum pratense) pollen profilin in Escherichia coli: comparison with birch pollen profilin.

  1994cited by this paper
• Molecular characterization of Phl p II, a major timothy grass (Phleum pratense) pollen allergen

  1993cited by this paper
• Properties of tree and grass pollen allergens: reinvestigation of the linkage between solubility and allergenicity.

  1993cited by this paper
• cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl pV allergen.

  1993cited by this paper
• Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

  1993cited by this paper
• Mechanism of grass-pollen-induced asthma.

  1992cited by this paper
• Diagnosis of grass pollen allergy with recombinant timothy grass (Phleum pratense) pollen allergens.

  1992cited by this paper
• Recombinant allergens for immunoblot diagnosis of tree-pollen allergy.

  1991cited by this paper
• IgE and IgG antibodies of patients with allergy to birch pollen as tools to define the allergen profile of Betula verrucosa*

  1989cited by this paper
• Cloning and expression of DNA coding for the major house dust mite allergen Der p 1 in Escherichia coli.

  1988cited by this paper
• Standardized extracts modified allergens-allergoids

  1987cited by this paper
• [Allergologic-immunochemical study of tree and bush pollen. III--Cross reactions of human IgE antibodies with various tree pollen allergens].

  1987cited by this paper
• Cross-reactivity of IgE antibodies with allergens in birch pollen, fruits and vegetables.

  1984cited by this paper
• Isolation and immunochemical characterization of the major allergen of birch pollen (Betula verrucosa).

  1983cited by this paper
• Mite faeces are a major source of house dust allergens

  1981cited by this paper
• Studies on allergoids from naturally occurring allergens. III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps.

  1981cited by this paper
• Immunological properties of conjugates of ragweed pollen antigen E with methoxypolyethylene glycol or a copolymer of D-glutamic acid and D- lysine

  1979cited by this paper

• Compilation of Evidence Supporting the Role of a T Helper 2 Reaction in the Pathogenesis of Acute Appendicitis

  2024cites this paper
• The use of aluminium hydroxide as adjuvant modulates the specific antibody response—A Brown Norway rat study with native and denatured cow's milk allergens

  2020cites this paper
• Nuevas medidas de diagnóstico eficiente en la hipersensibilidad alérgica al látex

  2019cites this paper
• Mucosal delivery of allergen peptides expressed by Lactococcus lactis inhibit allergic responses in a BALB/c mouse model

  2016cites this paper
• The Use of Adjuvants for Enhancing Allergen Immunotherapy Efficacy.

  2016cites this paper
• Estado actual y expectativas de futuro de la inmunoterapia con alérgenos en el asma Current status and future expectations of immunotherapy with allergens in asthma

  2016cites this paper
• Identification of olive pollen allergens using a fluorescence‐based 2D multiplex method

  2015cites this paper
• Defining thresholds of specific IgE levels to grass pollen and birch pollen allergens improves clinical interpretation.

  2015cites this paper
• Dimerisation increases the immunogenicity of recombinant Parj1/Parj2 allergens

  2015cites this paper
• Diagnosis of food allergy Part 2. The use of allergen components for in vitro diagnosis of food allergy in children

  2014cites this paper
• Peanut Bioinformatics: Tools and Applications for Developing More Effective Immunotherapies for Peanut Allergy and Improving Food Safety

  2014cites this paper
• Personalisierte Ansätze zur Diagnostik und Therapie von Allergien

  2013cites this paper
• The protein structure determines the sensitizing capacity of Brazil nut 2S albumin (Ber e1) in a rat food allergy model

  2013cites this paper
• Blomia tropicalis Blo t 5 and Blo t 21 recombinant allergens might confer higher specificity to serodiagnostic assays than whole mite extract

  2013cites this paper
• Sensitization to timothy grass pollen allergenic molecules in children

  2013cites this paper
• In silico Identification of IgE-Binding Epitopes of Osmotin Protein

  2013cites this paper
• Analysis Of Ige Reactivity To Pru Du 6, An 11s Globulin From Almond Nut, And Identification Of Both Sequential And Conformational Epitopes

  2013cites this paper
• [Personalised medicine for the diagnosis and treatment of allergic diseases].

  2013cites this paper
• Validity of using recombinant melon profilin, Cuc m 2, for diagnosis of melon allergy.

  2012cites this paper
• Synthesis of hypoallergenic derivatives of the major allergen Fag t 1 from tartary buckwheat via sequence restructuring.

  2012cites this paper
• [Current status and future expectations of immunotherapy with allergens in asthma].

  2012cites this paper
• Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose‐ranging safety study

  2012cites this paper
• Sensitization to Per a 2 of the American cockroach correlates with more clinical severity among airway allergic patients in Taiwan.

  2012cites this paper
• Structural and functional analyses of IgE epitopes and their biological relevance

  2012cites this paper
• Cloning, Expression and Patient IgE Reactivity of Recombinant Pru du 6, an 11S Globulin from Almond

  2011cites this paper
• Treatment with a Fel d 1 hypoallergen reduces allergic responses in a mouse model for cat allergy

  2011cites this paper
• Allergen-specific immunotherapy with recombinant allergens.

  2011cites this paper
• Protein unfolding strongly modulates the allergenicity and immunogenicity of Pru p 3, the major peach allergen.

  2011cites this paper
• Multiple protein extract microarray for profiling human food-specific immunoglobulins A, M, G and E.

  2011cites this paper
• Immunological approaches for tolerance induction in allergy.

  2011cites this paper
• L’utilizzo degli allergeni ricombinanti nell’iter diagnostico in allergologia pediatrica

  2011cites this paper
• [Allergen immunotherapy in Iceland 1977-2006].

  2010cites this paper
• Microarrays: molecular allergology and nanotechnology for personalised medicine (I).

  2010cites this paper
• Árangur afnæmismeðferðar á Íslandi 1977-2006

  2010cites this paper
• Dialogue aux frontières du soi : de l’allergie à l’épithélium et aux cellules dendritiques des voies aériennes et digestives

  2010cites this paper
• Display of wasp venom allergens on the cell surface of Saccharomyces cerevisiae

  2010cites this paper
• WITHDRAWN: An investigation on the protective efficiency of recombinant ovalbumin and its mutants against anaphylaxis in mice.

  2010cites this paper
• A deletion variant of the Aspergillus fumigatus ribotoxin Asp f 1 induces an attenuated airway inflammatory response in a mouse model of sensitization.

  2010cites this paper
• Allergen cross reactions: a problem greater than ever thought?

  2010cites this paper
• The current state of recombinant allergens for immunotherapy

  2010cites this paper
• Isolation and immunological characterization of a novel Cladosporium herbarum allergen structurally homologous to the alpha/beta hydrolase fold superfamily.

  2010cites this paper
• Microarrays: Molecular allergology and nanotechnology for personalised medicine (II).

  2010cites this paper
• La Component Resolved Diagnosis ( CRD ) : esempio concreto di personalizzazione della diagnosi

  2009cites this paper
• Contribution of molecular diagnosis of allergy to the management of pediatric patients with allergy to pollen.

  2009cites this paper
• Molecular diagnosis in allergology: application of the microarray technique.

  2009cites this paper
• Probing the IgE-Binding Repertoire of Self-Antigens in Atopic Eczema

  2009cites this paper